HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: A secondary analysis

PLoS Medicine

Volumn 8, Issue 3, 2011, Pages

  Zeh, Clement ^a   Weidle, Paul J ^b   Nafisa, Lillian ^c   Lwamba, Humphrey M ^c   Okonji, Jully ^c   Anyango, Emily ^c   Bondo, Philip ^c   Masaba, Rose ^c,f   Fowler, Mary Glenn ^d,e   Nkengasong, John N ^b   Thigpen, Michael C ^a,b   Thomas, Timothy ^a,b,g  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

^f FAMILY HEALTH INTERNATIONAL   (United States)

^g NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR; NEVIRAPINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; BREAST FEEDING; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG DOSE INCREASE; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; PUERPERIUM; SINGLE DRUG DOSE; VIRUS LOAD; VIRUS MUTATION; VIRUS TRANSMISSION; CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG EFFECT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; KENYA; MOTHER; MUTATION; NEWBORN; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VERTICAL TRANSMISSION; VIROLOGY;

ANTI-HIV AGENTS; BREAST FEEDING; COHORT STUDIES; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KENYA; MOTHERS; MUTATION; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 79953690521     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000430     Document Type: Article

References (31)

1. UNAIDS (2008) Report on the global AIDS epidemic. UNAIDS 2008. Available: http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/globalreport/2008/jc1511_gr08_executivesummary_en.pdf. Accessed 26 February 2011.
2. Harambat J, Fassinou P, Becquet R, Toure P, Rouet F, et al. (2008) 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Cote d'Ivoire: a cohort study. BMC Public Health 8: 169.
3. Dabis F, Ekpini ER, (2002) HIV-1/AIDS and maternal and child health in Africa. Lancet 359: 2097-2104.
4. Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, et al. (1999) Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 353: 781-785.
5. Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, et al. (2003) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 362: 859-868.
6. UNICEF (2005) Unite for children, unite against AIDS campaign. Available: http://www.unicef.org/aids/index.html. Accessed 26 February 2011.
7. Heinig MJ, (2002) Breastfeeding decisions. Pediatrics 110: 1033-1034.
8. Heinig MJ, (2001) Host defense benefits of breastfeeding for the infant. Effect of breastfeeding duration and exclusivity. Pediatr Clin North Am 48: 105-123.
9. Heinig MJ, (1998) The American Academy of Pediatrics recommendations on breastfeeding and the use of human milk. J Hum Lact 14: 2-3.
10. Nommsen-Rivers L, Heinig MJ, (1997) HIV transmission via breastfeeding: reflections on the issues. J Hum Lact 13: 179-181.
11. Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, et al. (2003) A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 187: 725-735.
12. Mirochnick M, Siminski S, Fenton T, Lugo M, Sullivan JL, (2001) Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure. Pediatr Infect Dis J 20: 803-805.
13. Mirochnick M, Thomas T, Capparelli E, Zeh C, Holland D, et al. (2009) Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy. Antimicrob Agents Chemother 53: 1170-1176.
14. Thomas T, Masaba R, Ndivo R, Zeh C, Borkowf C, et al. (2011) Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding-The Kisumu Breastfeeding Study, Kenya: A Clinical Trial. PLoS Med 8: e1001015 doi:10.1371/journal.pmed.1001015.
15. World Health Organization (2003) Scaling up antiretroviral therapy in resource-limited settings. Treatment guidelines for a public health approach Geneva WHO.
16. Mofenson LM, McIntyre JA, (2000) Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet 355: 2237-2244.
17. Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, et al. (2002) Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA 288: 189-198.
18. United States Food and Drug Administration (2005) Public health advisory for nevirapine (Viramune). Available: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051674.htm. Accessed 26 February 2011.
19. Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, et al. (2008) Update of the drug resistance mutations in HIV-1: spring 2008. Top HIV Med 16: 62-68.
20. Swofford DL, (2001) PAUP: Phylogenetic analysis using parsimony, version 4. Sunderland (Massachusetts) Sinauer.
21. Lidstrom J, Guay LA, Musoke P, Owor M, Onyango-Makumbi C, et al. (2010) Multi-class drug resistance arises frequently in hiv-infected breastfeeding infants whose mothers initiate highly active antitetroviral therapy (HAART) post-partum [Abstract]. The 17th Conference on Retroviruses and Opportunistic Infections; 16-19 February 2010; San Francisco (California, United States). pp 433
22. Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, et al. (2001) Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS 15: 1951-1957.
23. World Health Organization (2007) HIV transmission through breastfeeding; a review of available evidence; an update from 2001 to 2007. Available: http://whqlibdoc.who.int/publications/2008/9789241596596_eng.pdf. Accessed 26 February 2011.
24. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, et al. (2008) Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 359: 2233-2244.
25. Corbett A, Martinson F, Rezk N, Kashuba A, Jamieson D, et al. (2008) Antiretroviral drug concentrations in breastmilk and breastfeeding infants. The 15th Conference on Retroviruses and Opportunistic Infections; 3-6 February 2008; Boston (Massachusetts, United States) CROI 2008.
26. Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, et al. (2008) Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 359: 119-129.
27. Moorthy A, Gupta A, Sastry J, Venkatramani V, Bbosale R, et al. (2008) Timing of infection is critical for nevirapine resistance outcomes among breastfed subtype C HIV-1 infected infants exposed to extended vs single-dose NVP prophylaxis: The India SWEN Study [Abstract 44, 86 2008]. The 15th Conference on Retroviruses and Opportunistic Infections; 3-6 February 2008; Boston (Massachusetts, United States).
28. Church JD, Omer SB, Guay LA, Huang W, Lidstrom J, et al. (2008) Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. J Infect Dis 198: 1075-1082.
29. Colebunders R, Hodossy B, Burger D, Daems T, Roelens K, et al. (2005) The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk. AIDS 19: 1912-1915.
30. Yang C, Li M, Shi YP, Winter J, van Eijk AM, et al. (2004) Genetic diversity and high proportion of intersubtype recombinants among HIV type 1-infected pregnant women in Kisumu, western Kenya. AIDS Res Hum Retroviruses 20: 565-574.
31. World Health Organization (2007) HIV and Infant feeding Update. Available: http://whqlibdoc.who.int/publications/2007/9789241595964_eng.pdf. Accessed 28 February 2011.